The global Neuromodulation Devices and Implantable Infusion Pumps market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson"s disease, Epilepsy, etc.

The global Neuromodulation Devices and Implantable Infusion Pumps market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Neuromodulation Devices and Implantable Infusion Pumps Sales Market Report

Report Metric	Details
Report Name	Neuromodulation Devices and Implantable Infusion Pumps Sales Market
By Type: (Dominant Segment vs High-Margin Innovation)	Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Transcranial Magnetic Stimulation Transcutaneous Electrical Stimulation Other
By Application: (Core Demand Driver vs Emerging Opportunity)	Parkinson's Disease Epilepsy Pain Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Neuromodulation Devices and Implantable Infusion Pumps market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Deep Brain Stimulation in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Epilepsy in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Neuromodulation Devices and Implantable Infusion Pumps value chain, addressing:

FAQ for this report

What is the market share of major companies in Neuromodulation Devices and Implantable Infusion Pumps Sales Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Neuromodulation Devices and Implantable Infusion Pumps Sales Market share by type?

Ans: In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%.

Who are the main players in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market report?

Ans: The main players in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical

What are the Application segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market report?

Ans: The Applications covered in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market report are Parkinson's Disease, Epilepsy, Pain, Other

What are the Type segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market report?

Ans: The Types covered in the Neuromodulation Devices and Implantable Infusion Pumps Sales Market report are Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial Magnetic Stimulation, Transcutaneous Electrical Stimulation, Other

1 Market Overview

1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Scope

1.2 Neuromodulation Devices and Implantable Infusion Pumps by Type

1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020 & 2024 & 2031)

1.2.2 Spinal Cord Stimulation

1.2.3 Deep Brain Stimulation

1.2.4 Sacral Nerve Stimulation

1.2.5 Vagal Nerve Stimulation

1.2.6 Gastric Stimulation

1.2.7 Transcranial Magnetic Stimulation

1.2.8 Transcutaneous Electrical Stimulation

1.2.9 Other

1.3 Neuromodulation Devices and Implantable Infusion Pumps by Application

1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Pain

1.3.5 Other

1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts (2020-2031)

1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2020-2025)

2.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2020-2025)

2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Prospective (2020-2031)

2.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size and Prospective (2020-2031)

2.4.3 China Neuromodulation Devices and Implantable Infusion Pumps Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Type (2020-2025)

3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025)

3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2020-2025)

3.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2020-2025)

3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2026-2031)

3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2026-2031)

3.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2026-2031)

3.3 Different Types Neuromodulation Devices and Implantable Infusion Pumps Representative Players

4 Global Market Size by Application

4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Application (2020-2025)

4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025)

4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2020-2025)

4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2020-2025)

4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2026-2031)

4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2026-2031)

4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Neuromodulation Devices and Implantable Infusion Pumps Application

5 Competition Landscape by Players

5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Players (2020-2025)

5.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Players by Revenue (2020-2025)

5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2024)

5.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application

5.7 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Company

6.1.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025)

6.1.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025)

6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2020-2025)

6.1.3 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2020-2025)

6.1.4 North America Neuromodulation Devices and Implantable Infusion Pumps Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Company

6.2.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025)

6.2.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025)

6.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2020-2025)

6.2.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2020-2025)

6.2.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Company

6.3.1.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025)

6.3.1.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025)

6.3.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2020-2025)

6.3.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2020-2025)

6.3.4 China Neuromodulation Devices and Implantable Infusion Pumps Major Customer

6.3.5 China Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Medtronic

7.1.1 Medtronic Company Information

7.1.2 Medtronic Business Overview

7.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.1.5 Medtronic Recent Development

7.2 Boston Scientific Corporation

7.2.1 Boston Scientific Corporation Company Information

7.2.2 Boston Scientific Corporation Business Overview

7.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.2.5 Boston Scientific Corporation Recent Development

7.3 St. Jude Medical

7.3.1 St. Jude Medical Company Information

7.3.2 St. Jude Medical Business Overview

7.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.3.5 St. Jude Medical Recent Development

7.4 Synapse Biomedical

7.4.1 Synapse Biomedical Company Information

7.4.2 Synapse Biomedical Business Overview

7.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.4.5 Synapse Biomedical Recent Development

7.5 Nevro Corporation

7.5.1 Nevro Corporation Company Information

7.5.2 Nevro Corporation Business Overview

7.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.5.5 Nevro Corporation Recent Development

7.6 Neuropace

7.6.1 Neuropace Company Information

7.6.2 Neuropace Business Overview

7.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.6.5 Neuropace Recent Development

7.7 Cyberonics

7.7.1 Cyberonics Company Information

7.7.2 Cyberonics Business Overview

7.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.7.5 Cyberonics Recent Development

7.8 Autonomic Technologies

7.8.1 Autonomic Technologies Company Information

7.8.2 Autonomic Technologies Business Overview

7.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.8.5 Autonomic Technologies Recent Development

7.9 Avery Biomedical

7.9.1 Avery Biomedical Company Information

7.9.2 Avery Biomedical Business Overview

7.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.9.5 Avery Biomedical Recent Development

7.10 Greatbatch Medical

7.10.1 Greatbatch Medical Company Information

7.10.2 Greatbatch Medical Business Overview

7.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered

7.10.5 Greatbatch Medical Recent Development

8 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Analysis

8.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps

8.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors List

9.3 Neuromodulation Devices and Implantable Infusion Pumps Customers

10 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics

10.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends

10.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

10.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges

10.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific Corporation

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

List of Tables

Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Region (2020-2025)

Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2020-2025)

Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Region (2020-2025)

Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) Forecast by Region (2026-2031)

Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share Forecast by Region (2026-2031)

Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (Unit) & (2020-2025)

Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2020-2025)

Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (USD/Unit) & (2020-2025)

Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (Unit) & (2026-2031)

Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (USD/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (Unit) & (2020-2025)

Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2020-2025)

Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (USD/Unit) & (2020-2025)

Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (Unit) & (2026-2031)

Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (USD/Unit) & (2026-2031)

Table 27. New Sources of Growth in Neuromodulation Devices and Implantable Infusion Pumps Application

Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (Unit) & (2020-2025)

Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Company (2020-2025)

Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Company (2020-2025)

Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2024)

Table 33. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (USD/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application

Table 36. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025) & (Unit)

Table 39. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2020-2025)

Table 40. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2020-2025)

Table 42. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025) & (Unit)

Table 43. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2020-2025)

Table 44. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025) & (Unit)

Table 45. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2020-2025)

Table 46. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025) & (Unit)

Table 47. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2020-2025)

Table 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2020-2025)

Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025) & (Unit)

Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2020-2025)

Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025) & (Unit)

Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2020-2025)

Table 54. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2020-2025) & (Unit)

Table 55. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2020-2025)

Table 56. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2020-2025)

Table 58. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025) & (Unit)

Table 59. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2020-2025)

Table 60. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025) & (Unit)

Table 61. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2020-2025)

Table 62. Medtronic Company Information

Table 63. Medtronic Description and Business Overview

Table 64. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 65. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product

Table 66. Medtronic Recent Development

Table 67. Boston Scientific Corporation Company Information

Table 68. Boston Scientific Corporation Description and Business Overview

Table 69. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 70. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product

Table 71. Boston Scientific Corporation Recent Development

Table 72. St. Jude Medical Company Information

Table 73. St. Jude Medical Description and Business Overview

Table 74. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 75. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 76. St. Jude Medical Recent Development

Table 77. Synapse Biomedical Company Information

Table 78. Synapse Biomedical Description and Business Overview

Table 79. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 81. Synapse Biomedical Recent Development

Table 82. Nevro Corporation Company Information

Table 83. Nevro Corporation Description and Business Overview

Table 84. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 85. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product

Table 86. Nevro Corporation Recent Development

Table 87. Neuropace Company Information

Table 88. Neuropace Description and Business Overview

Table 89. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 90. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product

Table 91. Neuropace Recent Development

Table 92. Cyberonics Company Information

Table 93. Cyberonics Description and Business Overview

Table 94. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 95. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product

Table 96. Cyberonics Recent Development

Table 97. Autonomic Technologies Company Information

Table 98. Autonomic Technologies Description and Business Overview

Table 99. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 100. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product

Table 101. Autonomic Technologies Recent Development

Table 102. Avery Biomedical Company Information

Table 103. Avery Biomedical Description and Business Overview

Table 104. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 105. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 106. Avery Biomedical Recent Development

Table 107. Greatbatch Medical Company Information

Table 108. Greatbatch Medical Description and Business Overview

Table 109. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 110. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product

Table 111. Greatbatch Medical Recent Development

Table 112. Production Base and Market Concentration Rate of Raw Material

Table 113. Key Suppliers of Raw Materials

Table 114. Neuromodulation Devices and Implantable Infusion Pumps Distributors List

Table 115. Neuromodulation Devices and Implantable Infusion Pumps Customers List

Table 116. Neuromodulation Devices and Implantable Infusion Pumps Market Trends

Table 117. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

Table 118. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges

Table 119. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Picture

Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2024 & 2031

Figure 4. Spinal Cord Stimulation Product Picture

Figure 5. Deep Brain Stimulation Product Picture

Figure 6. Sacral Nerve Stimulation Product Picture

Figure 7. Vagal Nerve Stimulation Product Picture

Figure 8. Gastric Stimulation Product Picture

Figure 9. Transcranial Magnetic Stimulation Product Picture

Figure 10. Transcutaneous Electrical Stimulation Product Picture

Figure 11. Other Product Picture

Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2024 & 2031

Figure 14. Parkinson's Disease Examples

Figure 15. Epilepsy Examples

Figure 16. Pain Examples

Figure 17. Other Examples

Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2020-2031) & (US$ Million)

Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) Growth Rate (2020-2031)

Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends Growth Rate (2020-2031) & (USD/Unit)

Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered

Figure 23. Global Market Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2020 VS 2024

Figure 25. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. North America Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) Growth Rate (2020-2031)

Figure 27. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) Growth Rate (2020-2031)

Figure 29. China Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Growth Rate (2020-2031)

Figure 30. China Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) Growth Rate (2020-2031)

Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2020-2025)

Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2026-2031)

Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2026-2031)

Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2020-2025)

Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate by Application in 2020 & 2024

Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2026-2031)

Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2026-2031)

Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Company (2024)

Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Company (2024)

Figure 40. Global 5 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in Neuromodulation Devices and Implantable Infusion Pumps: 2020 & 2024

Figure 41. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 42. Manufacturing Cost Structure of Neuromodulation Devices and Implantable Infusion Pumps

Figure 43. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps

Figure 44. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain

Figure 45. Channels of Distribution (Direct Vs Distribution)

Figure 46. Distributors Profiles

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions